Legal Opinion
Geneva Pharmaceuticals Technology Corp. v. Barr Laboratories Inc.
Court of Appeals for the Second Circuit
Decided October 18, 2004No. Docket Nos. 02-9222, 02-9346PublishedCited by 3 opinions
1Opinion of the Court
CARDAMONE, Circuit Judge:
This civil antitrust action was instituted by plaintiffs-appellants Apothecon, Inc. and Geneva Pharmaceuticals Technology Corp., which manufacture and distribute a generic form of warfarin sodium, an anticoagulant medication (a blood thinner). The suit was brought under §§ 1 and 2 of the Sherman Antitrust Act, 15 U.S.C. § 1 and § 2 (2000). Those sections make it unlawful to enter into a contract, combination, or conspiracy in restraint of trade (§ 1), and/or to engage in a conspiracy to monopolize (§ 2). Plaintiffs’ antitrust claims are based on the alleged…
2Cases cited34 opinions
- Anderson v. Liberty Lobby, Inc.Supreme Court of the United States · 1986
- Celotex Corp. v. Catrett, Administratrix of the Estate of CatrettSupreme Court of the United States · 1986
- Matsushita Electric Industrial Co., Ltd. v. Zenith Radio CorporationSupreme Court of the United States · 1986
- Coopers & Lybrand v. LivesaySupreme Court of the United States · 1978
- United States v. Grinnell Corp.Supreme Court of the United States · 1966
29 more not listed; retrieve them via the Exa API.
3Cited by3 opinions
- Smith v. CommonwealthKentucky Supreme Court · 2012
- Geneva Pharmaceuticals Technology Corp. v. Barr Laboratories Inc.Court of Appeals for the Second Circuit · 2004
- In Re Remeron Direct Purchaser Antitrust LitigationDistrict Court, D. New Jersey · 2005